- E2F1 Reduces Sorafenib’s Sensitivity of Esophageal Carcinoma Cells via Modulating the miR-29c-3p/COL11A1 Signaling Axis
Zhifeng Ma et al, 2023, Current Molecular Pharmacology CrossRef - The Role of MicroRNAs in Hepatoblastoma Tumors
Ion Cristóbal et al, 2019, Cancers CrossRef - Integration of TE Induces Cancer Specific Alternative Splicing Events
Woo Ryung Kim et al, 2022, International Journal of Molecular Sciences CrossRef - A comparative characterization of the circulating miRNome in whole blood and serum of HCC patients
Devis Pascut et al, 2019, Scientific Reports CrossRef - DNMT1-induced miR-378a-3p silencing promotes angiogenesis via the NF-κB signaling pathway by targeting TRAF1 in hepatocellular carcinoma
Bin Zhu et al, 2021, Journal of Experimental & Clinical Cancer Research CrossRef - Molecular mechanism for metformin to enhance pro-apoptotic effect of sorafenib in HepG2 cells
Yan-Qing Ye et al, 2020, World Chinese Journal of Digestology CrossRef - MicroRNAs Targeting HIF-2α, VEGFR1 and/or VEGFR2 as Potential Predictive Biomarkers for VEGFR Tyrosine Kinase and HIF-2α Inhibitors in Metastatic Clear-Cell Renal Cell Carcinoma
Lisa Kinget et al, 2021, Cancers CrossRef - Regulators at Every Step—How microRNAs Drive Tumor Cell Invasiveness and Metastasis
Tomasz M. Grzywa et al, 2020, Cancers CrossRef - MiR-378a-3p Acts as a Tumor Suppressor in Colorectal Cancer Stem-Like Cells and Affects the Expression of MALAT1 and NEAT1 lncRNAs
Giorgia Castellani et al, 2022, Frontiers in Oncology CrossRef - MiRNAs as Anti-Angiogenic Adjuvant Therapy in Cancer: Synopsis and Potential
Behnaz Lahooti et al, 2021, Frontiers in Oncology CrossRef - The Mechanism of Rac1 in Regulating HCC Cell Glycolysis Which Provides Underlying Therapeutic Target for HCC Therapy
Yin-Xiang Ren et al, 2022, Journal of Oncology CrossRef - Hepigenetics: A Review of Epigenetic Modulators and Potential Therapies in Hepatocellular Carcinoma
Mohamed H. Yousef et al, 2020, BioMed Research International CrossRef